Risk of cancer after use of fertility drugs with in-vitro fertilisation
- 1 November 1999
- journal article
- Published by Elsevier in The Lancet
- Vol. 354 (9190) , 1586-1590
- https://doi.org/10.1016/s0140-6736(99)05203-4
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Fertility drugs and the risk of breast cancerHuman Reproduction, 1999
- Fertility drugs and the risk of breast and ovarian cancers: results of a long-term follow-up studyFertility and Sterility, 1999
- Cancer Incidence in a Cohort of Infertile WomanAmerican Journal of Epidemiology, 1998
- Time since childbirth and prognosis in primary breast cancer: population based studyBMJ, 1997
- Infertility, fertility drugs, and invasive ovarian cancer: a case-control studyFertility and Sterility, 1997
- Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studiesPublished by Elsevier ,1996
- Risk of Breast Cancer in a Cohort of Infertile WomenGynecologic Oncology, 1996
- Breast and ovarian cancer incidence after infertility and in vitro fertilisationPublished by Elsevier ,1995
- Transient Increase in the Risk of Breast Cancer after Giving BirthNew England Journal of Medicine, 1994
- A Controlled Study of Luteinizing Hormone–Releasing Hormone Agonist (Buserelin) for the Induction of Folliculogenesis before in Vitro FertilizationNew England Journal of Medicine, 1989